Arcellx files Schedule 13G/A for 4.5% stake
Arcellx Inc. Schedule 13G/A discloses that T. Rowe Price Investment Management, Inc. beneficially owned 2,653,848 shares of Arcellx common stock, representing 4.5% of the class as of 02/28/2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Arcellx Inc. Schedule 13G/A discloses that T. Rowe Price Investment Management, Inc. beneficially owned 2,653,848 shares of Arcellx common stock, representing 4.5% of the class as of 02/28/2026. The filing states sole voting power of 2,503,059 shares and sole dispositive power of 2,647,494. Item 5 notes ownership of 5 percent or less of a class.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did T. Rowe Price report for ACLX in the Schedule 13G/A?
Does the filing indicate T. Rowe Price controls more than 5% of ACLX?
What date is the ownership in the ACLX Schedule 13G/A measured as of?
Does the Schedule 13G/A imply beneficial ownership by an individual at T. Rowe Price?
AI-generated analysis. How Rhea-AI works. Not financial advice.